optimal_multiple_generic

This function is only used for documentation generation.

internal

Plan optimal sample size allocation and go/no-go decision rules
for phase II/III drug development programs with time-to-event, binary or
normally distributed endpoints when assuming fixed treatment effects or a
prior distribution for the treatment effect, using methods from Kirchner et al.
(2016) <doi:10.1002/sim.6624> and Preussler (2020). Optimal is in the sense of
maximal expected utility, where the utility is a function taking into account
the expected cost and benefit of the program. It is possible to extend to more
complex settings with bias correction (Preussler S et al. (2020)
<doi:10.1186/s12874-020-01093-w>), multiple phase III trials (Preussler et
al. (2019) <doi:10.1002/bimj.201700241>), multi-arm trials (Preussler et al.
(2019) <doi:10.1080/19466315.2019.1702092>), and multiple endpoints
(Kieser et al. (2018) <doi:10.1002/pst.1861>).

Lukas D. Sauer

drugdevelopR

Utility-Based Optimal Phase II/III Drug Development Planning

Stella Erdmann

Johannes Cepicka

Marietta Kirchner

Meinhard Kieser

optimal_multiple_generic function

<dl><dt>rho</dt>
<dd>correlation between the two endpoints</dd>
<dt>alpha</dt>
<dd>one-sided significance level/family-wise error rate</dd>
<dt>n2min</dt>
<dd>minimal total sample size in phase II, must be divisible by 3</dd>
<dt>n2max</dt>
<dd>maximal total sample size in phase II, must be divisible by 3</dd>
<dt>stepn2</dt>
<dd>stepsize for the optimization over n2, must be divisible by 3</dd>
<dt>fixed</dt>
<dd>assumed fixed treatment effect</dd></dl>

Arguments

Generic function for optimizing drug development programs with multiple endpoints — optimal_multiple_generic

<dl>

<dt>rho</dt>
<dd>correlation between the two endpoints</dd>


<dt>alpha</dt>
<dd>one-sided significance level/family-wise error rate</dd>


<dt>n2min</dt>
<dd>minimal total sample size in phase II, must be divisible by 3</dd>


<dt>n2max</dt>
<dd>maximal total sample size in phase II, must be divisible by 3</dd>


<dt>stepn2</dt>
<dd>stepsize for the optimization over n2, must be divisible by 3</dd>


<dt>fixed</dt>
<dd>assumed fixed treatment effect</dd>

</dl>

optimal_multiple_generic: Generic function for optimizing drug development programs with multiple endpoints

Description

Usage

Value

Arguments